Prognostic Value of KI6 Biomarker to Predict Short Term Prognosis of Low Grade Cervical Intraepithelial Neoplasia in Human Papilloma Virus Negative and Positive Patients.

Autor:	Seresht, Leila Mousavi, Sharifi, Noorieh, Najafi, Mona, Azimi, Helena, Babapour, Nooshin, Yousefi, Zohreh, Beheshtian, Nazanin, Nikooiyan, Yasaman
Předmět:	PAPILLOMAVIRUS disease diagnosis DNA analysis ACADEMIC medical centers BIOPSY COLPOSCOPY CYTOLOGY FISHER exact test GENE expression LONGITUDINAL method RESEARCH methodology PAP test PROBABILITY theory REGRESSION analysis STAINS & staining (Microscopy) SURVIVAL TUMOR markers DATA analysis software EARLY detection of cancer CERVICAL intraepithelial neoplasia MANN Whitney U Test TUMOR grading DIAGNOSIS
Zdroj:	Middle East Journal of Cancer; Jan2019, Vol. 10 Issue 1, p23-29, 7p, 1 Color Photograph, 2 Charts, 2 Graphs
Abstrakt:	Background: Cervical cancer is the most common gynecologic cancer in developing countries. Although this malignancy is preventable, problems exist with screening this cancer. Numerous studies have researchef immunohistochemistry methods, such as the KI-67 biomarker as a proliferation marker, to improve screening for cervical intraepithelial neoplasia as the precancerous phase of cervical cancer. Shese studies mostly screened cytological samples. In the current study, we sought to analyze the correlation between the KI-67 proliferative biomarker and HPV infection in order to predict short-time prognosis in cervical intraepithelial neoplasia as an alternative or ancillary method to current screening methods. Our assessment was based on histologic samples from a different geographic population. Methods: Shis descriptive cohort prospective study included 40 patients diagnosed with low grade cervical intraepithelial neoplasia based on cervical punch biopsy samples after colposcopy examination. We enrolled patients who referred to the Department of Gynecology- Oncology of an academic hospital of Mashhad University of Medical Sciences from 2016 to a017. All low grade cervical intraepithelial neoplasia samples were investigated for HR-HPV DNA with the Cobas test and immunostaining for the KI-67 biomarker. After a one-year follow-up, we evaluated the prognosis for all patients based on liquid based cytology and HR- HPV test. Data were analyzed by SPSS version 23.0 and the Mann-Whitney O and Fisher's exact tests. A P-value < 0.05 was consiferef significant. Results: We observed a significant difference between HR-HPV positive and negative tests in KI-67 expression (P<0.001), but there were no significant differences in reactivity level of cervical epithelium (P=0.5) and in KI-67 expressions in metaplastic and non-metaplastic epithelium (P=0.88). After one year, most low grade cervical intraepithelial neoplasia cases in group A that had a low staining KI-67 biomarker had evidence of regression. On the contrary, all cases with high grade KI-67 expression didn't persist or progressed necessarily. Conclusion: She KI-67 biomarker is recommenfef as a complementary screening test, but not an alternative for triage of high-risk patients with low grade cervical intraepithelial neoplasia. Patients with low grade cervical intraepithelial neoplfsif/HR-HPV positive cervical samples and low staining KI-67 antigen could be offered a less aggressive follow-up protocol. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu